Abstract
A new sensitiser (4) for use in photodynamic therapy (PDT) has beendeveloped to enable control of ROS production as a function of pH.This pH dependent PDT behaviour was tested in HeLa cells and in SCIDmice bearing human xenograft pancreatic cancer (BxPC-3) tumours.
Original language | English |
---|---|
Pages (from-to) | 16832-16835 |
Number of pages | 4 |
Journal | Chemical Communications |
Volume | 15 |
Early online date | 30 Sept 2015 |
DOIs | |
Publication status | Published (in print/issue) - 7 Dec 2015 |
Keywords
- PDT
- ROS
- sensitiser
- pH-controlled